Strictinin
Based on 1 Customer Validation
Strictinin is an orally active phenolic compound. Strictinin reduces xanthine oxidase activity, uric acid production, and the activation of ERK1/2, JNK, NF-κB, and NLRP3 inflammasome components in hepatocytes treated with Xanthine (HY-W017389). Strictinin decreases elevated serum uric acid levels and enhanced xanthine oxidase activity in mice treated with potassium oxonate. Strictinin acts as a ROR1 inhibitor and exhibits anticancer activity against highly aggressive non-androgen-dependent prostate cancer. Strictinin induces cancer cell apoptosis (apoptosis), arrests cell cycle, and inhibits cancer cell migration, invasion, and epithelial-mesenchymal transition. Strictinin modulates gut microbiota, inhibits bacterial growth and biofilm formation, accelerates small intestinal transit, and blocks viral entry and replication. Strictinin can be used in research related to hyperuricemia, androgen receptor-negative non-androgen-dependent prostate cancer, triple-negative breast cancer, bacterial infections, constipation, coronavirus infections, dental caries, and infections caused by influenza A, influenza B, and human parainfluenza virus type 1.
For research use only. We do not sell to patients.
- Purity : 97.15%
- CAS No.: 517-46-4
- Formula: C27H22O18
- Molecular Weight:634.45
-
Storage:Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
Biological Activity
Description
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | ED50 |
>10 μg/mL
Compound: 22
|
Cytotoxicity against human A549 cells by tetrazolium salt-based colorimetric assay
Cytotoxicity against human A549 cells by tetrazolium salt-based colorimetric assay
|
[PMID: 1431932] |
| HCT-8 | ED50 |
>10 μg/mL
Compound: 22
|
Cytotoxicity against human HCT8 cells by tetrazolium salt-based colorimetric assay
Cytotoxicity against human HCT8 cells by tetrazolium salt-based colorimetric assay
|
[PMID: 1431932] |
| KB | ED50 |
>10 μg/mL
Compound: 22
|
Cytotoxicity against human KB cells by tetrazolium salt-based colorimetric assay
Cytotoxicity against human KB cells by tetrazolium salt-based colorimetric assay
|
[PMID: 1431932] |
| TE-671 | ED50 |
>10 μg/mL
Compound: 22
|
Cytotoxicity against human TE671 cells by tetrazolium salt-based colorimetric assay
Cytotoxicity against human TE671 cells by tetrazolium salt-based colorimetric assay
|
[PMID: 1431932] |
In Vitro
Strictinin (50-500 μM; 24 h) exhibits cytotoxicity against AML12 mouse hepatocytes only at the concentration of 500 μM[1].
Strictinin (100-250 μM; 4-24 h) inhibits XOD activity and uric acid (UA) production in Xanthine (HY-W017389)-treated AML12 mouse hepatocytes, and suppresses IL-1β expression in these cells[1].
Strictinin (250 μM; 6 h) inhibits the activation of ERK1/2, JNK, NF-κB, and components of the NLRP3 inflammasome (NLRP3, ASC, caspase-1, cleaved caspase-1) in Xanthine-induced AML12 mouse hepatocytes[1].
Strictinin (31.25-1000 μM; 72 h) potently inhibits the viability of PC3 cells with an IC50 of 277.2 μmol/L, whereas its toxicity toward normal RWPE-1 cells is much lower (IC50 = 658.5 μmol/L)[2].
Strictinin (250 μM; 24-72 h) induces significant apoptosis in PC3 cells, reduces the number of viable cells, increases the populations of total apoptotic and dead cells, and triggers caspase 3/7-mediated apoptosis[2].
Strictinin (250 μM; 24-48 h) inhibits the expression of ROR1 in PC3 and DU145 cells, blocks the downstream PI3K-AKT-GSK3β pro-survival signaling pathway, and suppresses the expression of EMT markers Twist1, Snail and MMP9 in the cells[2].
Strictinin (125-250 μM; 24 h) inhibits migration and invasion of PC3 cells[2].
Strictinin (250 μM; 48-72 h) induces S-phase cell cycle arrest in PC3 cells[2].
Strictinin (125-1000 μg/mL; 24-72 h) reduces the viability of MDA-MB-231 and BT-549 triple-negative breast cancer (TNBC) cells in a dose-dependent manner, and its cytotoxicity depends on the expression of ROR1[3].
Strictinin (62.5-125 μg/mL; 24 h) inhibits the activity of the PI3K/AKT pathway in MDA-MB-231 and BT-549 triple-negative breast cancer (TNBC) cells[3].
Strictinin (125 μg/mL; 3-24 h) time-dependently inhibits the phosphorylation of AKT and GSK3β, reduces XIAP levels, inhibits Bad phosphorylation, and induces caspase-9 cleavage in MDA-MB-231 and BT-549 triple-negative breast cancer (TNBC) cells[3].
Strictinin (125-250 μg/mL) dose-dependently induces apoptosis in MDA-MB-231 and BT-549 triple-negative breast cancer (TNBC) cells[3].
Strictinin (62.5-125 μg/mL; 3-12 h post-wounding) inhibits the migration and invasion of MDA-MB-231 and BT-549 triple-negative breast cancer (TNBC) cells[3].
Strictinin inhibits the growth of *Cutibacterium acnes* (MIC = 250 μM) and *Staphylococcus epidermidis* (MIC = 2000 μM)[4].
Strictinin (4-100 µM) inhibits MHV plaque formation in mouse L cells in a concentration-dependent manner. Under the condition of full co-treatment, 100 µM Strictinin completely blocks plaque formation, while 20 µM reduces the plaque formation rate to <25% of that in the control group[5].
Strictinin (100 µM; administered during infection, harvested at 12 and 24 hpi) completely abrogates the expression of viral nucleocapsid protein in MHV-infected mouse L cells[5].
Strictinin (20-500 μM; 24 h) dose-dependently inhibits biofilm formation by Streptococcus mutans and Streptococcus sobrinus[6].
Strictinin (0.01-75 μM; 72 h) exhibits cytotoxicity against MDCK cells, with a CC50 of 5 μM after 72 h[7].
When added simultaneously with viral inoculation, Strictinin (2-8 μM; 1 h inoculation + 48 h incubation) inhibits the replication of influenza B virus in MDCK cells[7].
Strictinin (5-20 μM; 1 h inoculation + 48 h incubation) inhibits replication of human parainfluenza virus type 1 in LLC-MK2 cells in vitro in a dose-dependent manner when added concurrently with viral inoculation[7].
Strictinin (1-10 μM; 1 h) inhibits A/WSN/33 (H1N1) influenza A virus-induced semi-fusion in COS-7 cells at concentrations of 1 and 10 μM[7].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:AML12 mouse hepatocytes
-
Concentration:50 μM; 100 μM; 250 μM; 500 μM
-
Incubation Time:24 h
-
Result:Did not significantly reduce cell viability at 50, 100, or 250 μM.
Caused a statistically significant reduction in cell viability at 500 μM.
-
Cell Line:xanthine-treated AML12 mouse hepatocytes
-
Concentration:250 μM (co-treated with 100 μM Xanthine)
-
Incubation Time:6/24 h
-
Result:Inhibited xanthine-induced activation of ERK1/2, JNK, and NF-κB.
Reduced xanthine-induced upregulation of NLRP3, ASC, caspase-1, and cleaved caspase-1 protein expressions.
Significantly decreased the expression of cleaved IL-1β, particularly in xanthine-treated cells.
-
Cell Line:PC3 (androgen-receptor negative androgen-independent prostate cancer) cells, RWPE-1 (normal prostatic epithelial) cells
-
Concentration:31.25, 62.5, 125, 250, 500, 1000 μM
-
Incubation Time:72 h
-
Result:Exhibited selective cytotoxicity, with an IC50 of 277.2 μmol/L in PC3 cells.
Showed 2.4-fold lower IC50 in PC3 cells than the IC50 of 658.5 μmol/L in RWPE-1 cells.
-
Cell Line:PC3 androgen-receptor negative androgen-independent prostate cancer cells
-
Concentration:250 μM
-
Incubation Time:72 h
-
Result:Led to a significant decrease in live PC3 cells.
Caused significant increases in early apoptotic, late apoptotic, dead, and total apoptotic cell populations compared to vehicle control.
Showed a shift from live cells to apoptotic/dead cells in representative flow cytometry profiles.
Increased the percentage of apoptotic and dead PC3 cells in a time-dependent manner.
Showed a greater effect after 48 h compared to 24 h and vehicle control, as indicated by elevated caspase 3/7 activity.
-
Cell Line:PC3 androgen-receptor negative androgen-independent prostate cancer cells
-
Concentration:250 μmol/L
-
Incubation Time:24 h; 48 h
-
Result:Reduced ROR1 protein expression, with greater reduction after 48 h than 24 h.
Decreased the ratios of p-AKT/AKT and p-GSK3β/GSK3β.
Indicated inhibition of ROR1-mediated PI3K-AKT-GSK3β pro-survival signaling.\nReduced the expression of Twist1, Snail, and MMP9 in PC3 cells.
Showed greater reductions in Twist1, Snail, and MMP9 expression after 48 h compared to 24 h.
-
Cell Line:PC3 androgen-receptor negative androgen-independent prostate cancer cells, RWPE-1 normal prostatic epithelial cells
-
Concentration:125, 250 μmol/L
-
Incubation Time:24 h
-
Result:Reduced percent wound healed in PC3 cells in a concentration-dependent manner.
Caused a significant reduction in percent wound healed in PC3 cells at 250 μmol/L compared to control.
Did not significantly change percent wound healed in RWPE-1 cells compared to control.
-
Cell Line:PC3 androgen-receptor negative androgen-independent prostate cancer cells, RWPE-1 normal prostatic epithelial cells
-
Concentration:250 μmol/L
-
Incubation Time:24 h
-
Result:Significantly reduced the percentage area covered by invaded PC3 cells compared to control.
Did not significantly change invasion in RWPE-1 cells compared to control.
-
Cell Line:PC3 androgen-receptor negative androgen-independent prostate cancer cells, RWPE-1 normal prostatic epithelial cells
-
Concentration:125 μmol/L; 250 μmol/L
-
Incubation Time:24 h (125 μmol/L; 250 μmol/L PC3); 48 h (250 μmol/L PC3); 72 h (250 μmol/L RWPE-1)
-
Result:Caused an S-phase cell cycle arrest in PC3 cells, with a ~5% increase in S-phase cells after 48 h of 250 μmol/L treatment compared to control.
Caused a ~2% increase in S-phase cells in RWPE-1 cells after 250 μmol/L treatment for 72 h compared to control.
In Vivo
Strictinin (0.25-0.5 g/kg; p.o.; single administration) exerts a dose-dependent laxative effect in rats by accelerating small intestinal transit, without altering food intake, inducing diarrhea, or promoting gastric emptying[4].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:ICR (8-week-old male; hyperuricemia induced by oral gavage of potassium oxonate)[1]
-
Dosage:400 mg/kg; 700 mg/kg; 1000 mg/kg
-
Administration:p.o.; single weekly; 7 days
-
Result:Significantly reduced elevated liver xanthine oxidase activity and serum uric acid level induced by potassium oxonate.
Prevented slight renal tubular dilation damage observed in potassium oxonate-treated mice.
Significantly elevated proportions of Clostridium thermosuccinogenes, Marvinbryantia formatexigens, and Ruminococcus lactaris in gut microbiota.
Significantly reduced proportions of Clostridium aldenense, Clostridium cellulovorans, Clostridium lavalense, Clostridium saccharolyticum, Clostridium symbiosum, Ruminococcus gauvreauii, Roseburia faecis, and Ruminococcus gnavus in gut microbiota compared to potassium oxonate-only treated mice.
Caused no significant liver damage in treated groups.
-
Animal Model:Sprague-Dawley (male, 200-250 g)[4]
-
Dosage:0.25 g/kg; 0.5 g/kg
-
Administration:p.o.; single dose
-
Result:Increased feces weight significantly relative to controls at 6 hs post-administration (0.25 g/kg dose).
Increased feces weight significantly relative to controls at 6, 12, and 24 h post-administration, with a stronger effect at the higher dose (0.5 g/kg dose).
Showed no significant change in gastric emptying percentage relative to controls (0.5 g/kg dose).
Accelerated small intestinal transit percentage significantly relative to controls (0.5 g/kg dose).
Caused no significant differences in food intake or fecal water content relative to controls.
Chemical Information
-
CAS No. 517-46-4
-
Appearance Solid
-
Molecular Weight 634.45
-
Formula C27H22O18
-
Color White to off-white
-
SMILES
O[C@H]1[C@H](OC(C2=CC(O)=C(O)C(O)=C2)=O)O[C@H](COC3=O)[C@@H](OC(C4=CC(O)=C(O)C(O)=C4C5=C(O)C(O)=C(O)C=C53)=O)[C@@H]1O
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years In solvent -80°C 6 months -20°C 1 month
Solvent & Solubility
In Vitro:
H2O : 50 mg/mL (78.81 mM; Need ultrasonic)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Protocols
-
Scratch/Wound-Healing Migration Assay
The scratch/wound-healing migration assay measures collective migration of adherent cells into an experimentally created cell-free gap in a confluent monolayer. The readout is generated by imaging the gap immediately after scratching and at later time points, then quantifying reduction in wound area, wound width, or percentage closure as cells move into the denuded region. Gap closure reflects cell migration but may also include cell proliferation, so interpretation should distinguish migration-focused conditions from proliferation-driven closure when possible, such as by using short assay windows, serum-controlled conditions, cell counting, or proliferation controls reported in published protocols.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
BrdU Incorporation Assay
Bromodeoxyuridine (BrdU) incorporation assay is based on the principle that BrdU, a thymidine analog, is incorporated into newly synthesized DNA during the S phase of the cell cycle, thereby serving as a marker of DNA replication and cellular proliferation. Incorporated BrdU can be detected using anti-BrdU antibodies following DNA denaturation, enabling visualization or quantification of proliferating cells through immunochemical detection methods such as immunofluorescence or immunohistochemistry.
-
Cell migration
Cell migration is a method that plays an important role in wound healing, cell differentiation, embryonic development, etc.
-
Neural Crest/Neuronal Cell Migration Explant Assay
Neural crest (NC) and neuronal cell migration explant assays are in vitro systems in which neural tube-derived tissues are cultured to allow premigratory or newly emigrated neural crest cells to undergo epithelial-to-mesenchymal transition (EMT), migrate away from the explant, and form a measurable radial outgrowth that reflects migratory capacity and environmental responsiveness. These assays typically quantify migration by measuring the expansion of cell outgrowth from neural tube or neural plate border explants over time, often comparing early and later timepoints to derive a migration index such as a radius ratio, which reflects net cell dispersal from the explant core. Neural tube explant cultures preserve key aspects of neural crest behavior, including EMT, migration, and early differentiation, making them suitable for assessing intrinsic migratory ability and extrinsic cue dependence. However, studies emphasize that migratory outgrowth from neural tube explants may include non-n
-
Research Protocol for Microbiome Analysis
Microbiome analysis characterizes microbial communities in biological or environmental samples by measuring community composition, diversity, taxonomic structure, functional potential, and associations with host or environmental phenotypes. 16S rRNA gene amplicon sequencing is commonly used for bacterial and archaeal taxonomic profiling, while shotgun metagenomics provides higher taxonomic resolution and direct functional information, including microbial genes, pathways, viruses, fungi, and antimicrobial-resistance genes when sequencing depth and host-DNA contamination are adequately controlled. Microbiome results are strongly affected by sample collection, storage, DNA extraction, contamination, sequencing method, reference database, and bioinformatic pipeline; therefore, standardized protocols, negative controls, mock communities, and transparent analysis workflows are required. Unresolved issues include low-biomass contamination, compositional-data bias, inconsistent species-level c
-
Protocol for Cell Cycle
Cell-cycle analysis by flow cytometry measures DNA content in single cells to estimate the fraction of cells in G0/G1, S, and G2/M phases. Propidium iodide intercalates into DNA, and after RNA removal with RNase, fluorescence intensity reflects cellular DNA content: 2N cells are assigned to G0/G1, cells between 2N and 4N to S phase, and 4N cells to G2/M. DNA-content analysis alone cannot reliably separate G0 from G1 or G2 from M. Ki-67 can distinguish quiescent G0 cells from cycling cells, EdU or BrdU incorporation marks active DNA synthesis in S phase, and phospho-histone H3 staining identifies mitotic cells within the 4N population.
-
Research Protocol for Inflammation-related Diseases
The NLRP3 inflammasome is a cytosolic innate immune signaling platform that integrates priming signals and danger-signal activation to promote caspase-1 activation, maturation of IL-1β and IL-18, and gasdermin D-mediated pyroptotic cell death. The core experimental logic is to determine whether inflammatory disease phenotypes are driven by increased NLRP3 expression, ASC-containing inflammasome assembly, caspase-1 cleavage, GSDMD cleavage, and extracellular release of IL-1β/IL-18 rather than by nonspecific cell injury alone. The pathway is strongly linked to inflammation-related disease phenotypes because monosodium urate crystals activate NALP3/NLRP3 inflammasome signaling in gout-like crystal inflammation, cholesterol crystals activate NLRP3 inflammasomes in atherogenesis models, and DSS-induced intestinal inflammation has been reported to involve NLRP3 inflammasome activity. However, experimental colitis studies also show context-dependent protective effects of NLRP3 inflammasome co
-
Breast Cancer Modeling
Breast cancer is a heterogeneous cancer, and it has been distinguished into four subtypes: luminal A, luminal B, HER2-positive and basal-like. Molecular mutations, epigenetic alterations, hormone exposure and immune microenvironment are related to the progression of breast cancer.
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Flow cytometric DNA-content cell-cycle staining
Flow cytometric DNA-content cell-cycle staining measures the fluorescence intensity of DNA-bound fluorochromes in single cells or nuclei to estimate DNA content distributions, allowing assignment of populations to G0/G1, S, and G2/M phases by DNA histogram deconvolution. Propidium iodide (PI) intercalates into DNA, and PI fluorescence is proportional to cellular DNA content when staining is performed under conditions that make DNA accessible and minimize non-DNA signal. Cells with G2/M DNA content are expected to show approximately twice the fluorescence intensity of G0/G1 cells, while S-phase cells occupy intermediate fluorescence values. PI-based DNA-content analysis can also detect cells with fractional DNA content, often reported as sub-G1, when DNA fragmentation and extraction during staining reduce retained DNA signal in apoptotic cells. DAPI is an alternative DNA fluorochrome for univariate DNA-content analysis, while bivariate approaches combining DNA content with proliferation
-
Chemotaxis Gradient Chamber Assay 1
The chemotaxis gradient chamber assay is based on the principle of observing directional cell migration in response to a stable, linear or quasi-linear concentration gradient of a chemoattractant formed between two fluid reservoirs separated by a narrow observation chamber. Cells placed within the chamber respond to the gradient by polarized movement toward higher chemoattractant concentrations, allowing quantification of chemotactic behavior in real time under microscopy. The classic Zigmond chamber design enables simultaneous visualization of gradient formation and individual cell trajectories, making it suitable for studying leukocyte chemotaxis and other motile cell types in vitro.
-
Research Protocol for Endocrine Diseases
Endocrine diseases often arise from disrupted hormone production, hormone signaling, or target-tissue responsiveness; for diabetes-focused endocrine disease models, insulin signaling regulates glucose uptake, hepatic glucose output, lipid metabolism, and β-cell compensation. Type 2 diabetes develops through interacting defects in insulin resistance, β-cell dysfunction, adipose inflammation, hepatic glucose overproduction, altered incretin signaling, and ectopic lipid metabolism. A major unresolved question is whether endocrine dysfunction is driven primarily by target-tissue insulin resistance, intrinsic β-cell failure, immune/inflammatory stress, or combined multi-organ failure that differs by disease stage.
-
Under-Agarose Cell Migration Assay
The under-agarose cell migration assay is a classical in vitro chemotaxis method designed to evaluate directed cell movement through a semi-solid agarose matrix toward soluble chemoattractant gradients, enabling visualization and quantification of leukocyte or motile cell migration in a confined 2D-like environment. In this system, cells and chemoattractants are placed in separate wells cut into an agarose gel, allowing diffusion-driven gradient formation that guides directional migration, which is typically assessed by measuring migration distance, cell morphology changes, and accumulation toward the chemoattractant source. This assay has been widely used to study neutrophil and leukocyte chemotaxis as a simple alternative to filter-based migration systems and allows direct microscopic observation of migrating cells under near-physiological confinement conditions.
-
Aerobic Bacterial Batch Culture on Broth/Agar
Aerobic bacterial batch culture grows a closed inoculated population in broth or on agar without continuous medium replacement; growth readouts include turbidity/OD for total suspended biomass and colony-forming units for viable cells able to form colonies on agar. OD-based growth curves reflect light scattering by cells, but OD is instrument-, pathlength-, species-, cell-size-, and density-dependent, so OD should be calibrated or interpreted alongside viable counts when quantitative cell density is required.
-
Transwell/Boyden Chamber Migration Assay
The Transwell/Boyden chamber migration assay measures cell movement through a porous membrane separating an upper and lower chamber, usually after a chemoattractant gradient is established by placing cells in the upper chamber and chemoattractant-containing medium in the lower chamber. The readout is generated by quantifying cells that traverse the membrane and appear on the lower membrane surface or in the lower chamber, depending on whether the cell type is adherent or non-adherent. This assay reflects chemotactic or haptotactic migration rather than matrix invasion unless an extracellular-matrix barrier is added to the membrane.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
3D Collagen/Hydrogel Matrix Migration Assay
The 3D collagen/hydrogel matrix migration assay is based on embedding cells within or on top of a fibrillar collagen type I-rich three-dimensional matrix to model in vivo-like extracellular matrix (ECM) architecture, enabling analysis of cell migration through a physically and biochemically relevant scaffold. In contrast to 2D migration systems, cells in 3D matrices interact with fibrillar collagen networks, requiring coordinated adhesion remodeling and proteolytic or non-proteolytic deformation mechanisms to move through confined spaces, thereby providing a more physiologically relevant readout of invasive and migratory behavior in tissue-like environments. Cell movement in 3D collagen matrices is typically quantified by tracking single-cell trajectories, invasion depth, or matrix penetration over time, reflecting combined effects of cytoskeletal dynamics, cell-ECM adhesion turnover, and ECM remodeling. These systems are widely used to study tumor cell invasion and stromal cell motili
-
Cell invasion
Cell invasion is the ability of cells to migrate from one area to another via the extracellular matrix. Cell invasion is the response of normal and cancer cells to chemical and mechanical stimuli. Before migrating to a new region, the extracellular matrix is degraded by proteases within the cell. Cell invasion often occurs during wound repair, vascularization and inflammation, abnormal tissue invasion, and tumor cell metastasis.
-
Cell-Exclusion Zone Migration Assay
The Cell-Exclusion Zone (CEZ) migration assay is an in vitro 2D cell migration method in which a defined cell-free area is created using removable physical barriers such as silicone stoppers, allowing cells to be seeded around the barrier and subsequently migrate into the cleared zone after barrier removal. This approach enables quantification of collective cell migration by monitoring repopulation of the initially cell-free region over time using microscopy-based imaging. Compared with scratch-based wound healing assays, barrier-based exclusion methods are designed to avoid mechanical damage to the extracellular matrix and reduce injury-induced effects on boundary cells, thereby improving interpretability of migration behavior in vitro. The assay readout is typically the progressive reduction in the cell-free area or the number of cells invading the exclusion zone, reflecting coordinated cell motility relevant to physiological processes such as wound healing, epithelial repair, and ca
-
Chemotaxis Gradient Chamber Assay 2
Chemotaxis gradient chamber assays measure directional cell migration in response to a soluble chemical gradient by imaging cells as they move across a defined observation region; the readout is generated from time-lapse cell trajectories, displacement toward the gradient, forward migration index, trajectory plots, rose/polar plots, and statistical tests of non-random directionality. The Dunn chamber is a direct-viewing glass chamber in which cells migrate across a bridge between control and chemoattractant wells, allowing observation of cells in a linear concentration gradient; related direct-viewing formats include the Insall chamber, which supports defined unidirectional gradients and high numerical-aperture microscopy, and the μ-Slide Chemotaxis chamber, which supports long-term live-cell imaging and gradient characterization with fluorescent dye.
-
Fungal Biofilm Culture
Fungal biofilm culture is an in vitro method for growing surface-attached fungal communities, most commonly Candida albicans, on abiotic substrates such as polystyrene wells, silicone elastomer, or polymethylmethacrylate; the assay models adhesion, proliferation, filamentation, extracellular-matrix-associated maturation, and dispersion. Biofilm output can be read by optical density at 600 nm for adherent biomass, XTT reduction for metabolic activity, CFU recovery for viable attached or dispersed cells, and microscopy for architecture.
-
Pyroptosis Solutions
Pyroptosis is a lytic inflammatory cell-death pathway executed by gasdermin pores, most classically through inflammasome-mediated activation of caspase-1, cleavage of gasdermin D, membrane pore formation, LDH release, and secretion of IL-1β and IL-18. The canonical pathway is commonly modeled by priming cells with an inflammatory signal such as LPS to induce pro-IL-1β and inflammasome components, followed by an activation signal such as ATP or nigericin to activate NLRP3, ASC speck formation, caspase-1 cleavage, GSDMD cleavage, cytokine release, and pyroptotic membrane rupture. The non-canonical pathway is triggered when cytosolic LPS activates mouse caspase-11 or human caspase-4/5, leading to GSDMD cleavage and pyroptosis, and this can secondarily activate NLRP3-dependent IL-1β release. Pyroptosis is linked to inflammatory injury, infection, cancer, liver disease, ocular disease, placental inflammation, and other disease phenotypes, but unresolved questions include which gasdermin fam
Purity & Documentation
-
Data Sheet (296 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
References
[1]. Huang KC, et al. Alleviation of Hyperuricemia by Strictinin in AML12 Mouse Hepatocytes Treated with Xanthine and in Mice Treated with Potassium Oxonate. Biology (Basel). 2023;12(2):329. Published 2023 Feb 17. [Content Brief]
[2]. Sivaganesh V, et al. Receptor tyrosine kinase-like orphan receptor 1 inhibitor strictinin exhibits anti-cancer properties against highly aggressive androgen-independent prostate cancer. Explor Target Antitumor Ther. 2023;4(6):1188-1209. [Content Brief]
[3]. Fultang N, et al. Strictinin, a novel ROR1-inhibitor, represses triple negative breast cancer survival and migration via modulation of PI3K/AKT/GSK3ß activity. PLoS One. 2019;14(5):e0217789. Published 2019 May 31. [Content Brief]
[4]. Hsieh SK, et al. Antibacterial and laxative activities of strictinin isolated from Pu'er tea (Camellia sinensis). J Food Drug Anal. 2016;24(4):722-729. [Content Brief]
[5]. Tu EC, et al. Strictinin, a Major Ingredient in Yunnan Kucha Tea Possessing Inhibitory Activity on the Infection of Mouse Hepatitis Virus to Mouse L Cells. Molecules. 2023;28(3):1080. Published 2023 Jan 21. [Content Brief]
[6]. Liao MH, et al. Pu'er tea rich in strictinin and catechins prevents biofilm formation of two cariogenic bacteria, Streptococcus mutans and Streptococcus sobrinus. J Dent Sci. 2021 Oct;16(4):1331-1334. [Content Brief]
[7]. Saha RK, et al. Antiviral effect of strictinin on influenza virus replication. Antiviral Res. 2010;88(1):10-18. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| H2O | 1 mM | 1.5762 mL | 7.8808 mL | 15.7617 mL | 39.4042 mL |
| 5 mM | 0.3152 mL | 1.5762 mL | 3.1523 mL | 7.8808 mL | |
| 10 mM | 0.1576 mL | 0.7881 mL | 1.5762 mL | 3.9404 mL | |
| 15 mM | 0.1051 mL | 0.5254 mL | 1.0508 mL | 2.6269 mL | |
| 20 mM | 0.0788 mL | 0.3940 mL | 0.7881 mL | 1.9702 mL | |
| 25 mM | 0.0630 mL | 0.3152 mL | 0.6305 mL | 1.5762 mL | |
| 30 mM | 0.0525 mL | 0.2627 mL | 0.5254 mL | 1.3135 mL | |
| 40 mM | 0.0394 mL | 0.1970 mL | 0.3940 mL | 0.9851 mL | |
| 50 mM | 0.0315 mL | 0.1576 mL | 0.3152 mL | 0.7881 mL | |
| 60 mM | 0.0263 mL | 0.1313 mL | 0.2627 mL | 0.6567 mL |
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Keywords
- Strictinin
- 517-46-4
- Bacterial
- Antibiotic
- ERK
- JNK
- NF-κB
- ROR
- Apoptosis
- Caspase
- GSK-3
- Akt
- PI3K
- NLRP3 inflammasome
- MDA-MB-231 triple negative breast cancer cells
- ROR1
- Streptococcus mutans
- PI3K-AKT-GSK3β signaling
- PC3 androgen-receptor negative androgen-independent prostate cancer cells
- AML12 mouse hepatocytes
- influenza A virus
- xanthine oxidase
- Propionibacterium acnes
- phenolic compound
- ICR mice
- Sprague-Dawley rat
- Inhibitor
- inhibitor
- inhibit